Novel Molecular Targets for Mood Disorders and Psychosis Proceedings of a Workshop (2021) / Chapter Skim
Currently Skimming:
Appendix A: References
Appendix A: References
Pages 61-66
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 61... ...
2021. Allopregnanolone mediates affective switching through modulation of oscillatory states in the basolateral amygdala.
|
From page 62... ...
2019. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse preven tion in patients with treatment-resistant depression: A randomized clinical trial.
|
From page 63... ...
2018. Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam- controlled randomized clinical trial.
|
From page 64... ...
2014. Tonic GABAA conductance bidirectionally controls interneuron firing pattern and synchronization in the CA3 hippocampal network.
|
From page 65... ...
2008. Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.